Please specify the following points: 1. The specific methods of acupuncture in each study and the potential meta-analysis, thus to make sure the readers can understand what kind of data will be pooled together. 2. Please pay attention to syndrome in the systematic review. 
Page 10
Data extraction For all types of clinical studies, we will extract [61 63 64]: (4) Interventions (type of acupuncture and related therapy, acupuncture point selection, treatment frequency, number of sessions, duration of each session, point stimulation/manipulation method(s));
Page 12 Evidence synthesis for randomised controlled trials When conducting meta-analysis, for each outcome studies will be grouped according to: 1. the type of acupuncture (e.g. manual acupuncture, electroacupuncture, ear-acupuncture, acupressure, moxibustion and TENS); 2. the comparator (e.g. placebo/sham acupuncture, pharmaceutical therapy, usual care only); and 3. the specific type of pain such as breakthrough pain [72] , cancer-induced bone pain [73] or aromatase inhibitor-associated arthralgia [74] . Sensitivity analyses are planned based on clinical factors (cancer type, degree of pain, Chinese medicine syndrome/pattern), acupuncture method (stimulation method, dosage, specific acupuncture points), methodological characteristics (sample size, risk of bias), and presence of statistical heterogeneity as applicable.
Comment 2:
Please pay attention to syndrome in the systematic review. Response: Thank you for the suggestion. We have added further detail on syndrome/pattern differentiation in the relevant sections of the revised manuscript.
Changes to MS:
Page 4 Background Further, in traditional acupuncture the intervention is not standardised and can be adjusted according to the syndrome (zheng) of the individual patient [24 25] . One approach to addressing the need to assess acupuncture in realistic settings has been the adoption of pragmatic trial designs [26 27].
Page 10 Data extraction (3) Participants (type and/or stage of cancer, age, sex, type of pain, pain intensity before treatment, Chinese medicine syndrome); For both systematic reviews and clinical studies, information related to syndrome/pattern of Chinese medicine will be extracted, including therapeutic principles, Chinese medicine syndrome/pattern and related outcomes [65] .
Page 11 Evidence synthesis for systematic reviews We will report a summary of the findings of the systematic reviews and meta-analyses. For each review, this will include: the type of acupuncture and related therapies; syndrome/pattern in Chinese medicine, the type of cancer pain included (related to neoplasm, related to cancer therapy); Page 12 Evidence synthesis for randomised controlled trials Sensitivity analyses are planned based on clinical factors (cancer type, degree of pain, Chinese medicine syndrome/pattern), acupuncture method (stimulation method, dosage, specific acupuncture points), methodological characteristics (sample size, risk of bias), and presence of statistical heterogeneity as applicable.
Page 14
Concluding remarks Syndrome/pattern (zheng) differentiation is an essential notion in the theory of Chinese medicine that informs the selection and application of therapeutic interventions [83] . Randomized controlled trials and systematic reviews have examined the effects of syndrome differentiation in a number of disorders [84 85] . Syndromes distribution among advanced cancer patients with opioid-related constipation has been determined by a cross-sectional study [86] and treatment based on syndrome differentiation has been suggested [65] . Where possible, this review will examine effects related to the application of syndrome/pattern differentiation in the include studies and determine any implications for future clinical studies.
Reviewer 2: Dr Carole A Paley
Comment 1: The abstract starts with a sweeping statement -who recommends acupuncture for cancer pain? Response: Thank you for this comment. We have revised the introduction in the abstract to be specific.
Changes to MS: Page 1 Introduction: The NCCN Guidelines for adult cancer pain indicate that acupuncture and related therapies may be valuable additions to pharmacologic interventions for pain management.
Comment 2:
The background section is reasonably detailed but would benefit from some mention of the difficulties of designing an RCT with issues surrounding dose and the use of placebo/sham needles as these are not inert. These issues are highly significant and are relevant to the quality of RCTs.
Response: Thank you for your suggestion. We have included the issues relating to control methods in acupuncture, placebo/sham needles, and the dose of acupuncture in the background. Changes to MS: Page 4 Background From the perspective of research design for clinical trials, acupuncture presents a range of challenges. Acupuncture included a variety of methods and techniques which may not be directly comparable [19 20] . It is difficult to blind personnel and participants in RCTs. Sham/placebo acupuncture devices have been developed but there is some controversy about whether these and other control methods used in acupuncture studies are truly inert [20] [21] [22] . Another issue is whether the manipulation technique(s) used by the acupuncturist and the number of needles inserted impact on analgesia in a manner similar to medication dosage [20 23].
Comment 3:
The eligibility section is very wide-ranging, including pain related to treatments for cancer. Not all reviews include indirect pain and it is therefore difficult to compare them.
Response: Thanks you for mentioning this distinction. We did not cover these issues in sufficient detail. We deliberately set broad inclusion criteria in order to gain an overview of the current state of the evidence. As you have rightly pointed out, this will raise issues when comparing studies, so we have expanded on the sections relating to categorizing studies prior to any meta-analysis and issues relating to evidence synthesis.
Changes to MS: Page 11
Evidence synthesis for systematic reviews We will report a summary of the findings of the systematic reviews and meta-analyses. For each review, this will include: the type of acupuncture and related therapies; syndrome/pattern in Chinese medicine, the type of cancer pain included (related to neoplasm, related to cancer therapy); the number of included clinical studies; numbers of participants; the outcome measures assessed; any meta-analysis results for each outcome, heterogeneity, and reviewers' conclusions.
Page 12
Evidence synthesis for randomised controlled trials When conducting meta-analysis, for each outcome studies will be grouped according to: 1. the type of acupuncture (e.g. manual acupuncture, electroacupuncture, ear-acupuncture, acupressure, moxibustion and TENS); 2. the comparator (e.g. placebo/sham acupuncture, pharmaceutical therapy, usual care only); and 3. the specific type of pain such as breakthrough pain [72] , cancer-induced bone pain [73] or aromatase inhibitor-associated arthralgia [74] . Evidence synthesis for non-randomised studies Firstly, we will tabulate the characteristics of each of the non-randomised studies, the outcome measures and the reported results. Where possible, studies will be grouped according to study type, type of acupuncture intervention, type of control (if applicable), type of cancer pain, and study quality. Response: Thank you for this question. We will group studies according to the type of acupuncture intervention. Where possible we will calculate effect sizes for outcome measures reported in the RCTs and undertake data pooling if appropriate. This approach can produce measureable results for a particular intervention, provided that suitable data are available. For some interventions and outcomes we expect that suitable data will not be available so we will use a descriptive approach. Even in such cases, quantitative data on safety may be available. Overall we expect that measurable results for outcome measures will form one part of the synthesis with other parts depending on descriptive aspects, including consistency or inconsistency between studies, the quality of the available evidence, and identification of gaps in the available evidence. We have included further detail on these issues in the revised sections on evidence synthesis, and in the discussion of limitations.
Changes to MS: Page 11 Evidence synthesis for systematic reviews We will report a summary of the findings of the systematic reviews and meta-analyses. For each review, this will include: the type of acupuncture and related therapies; syndrome/pattern in Chinese medicine, the type of cancer pain included (related to neoplasm, related to cancer therapy); the number of included clinical studies; numbers of participants; the outcome measures assessed; any meta-analysis results for each outcome, heterogeneity, and reviewers' conclusions.
Evidence synthesis for randomised controlled trials When conducting meta-analysis, for each outcome studies will be grouped according to: 1. the type of acupuncture (e.g. manual acupuncture, electroacupuncture, ear-acupuncture, acupressure, moxibustion and TENS); 2. the comparator (e.g. placebo/sham acupuncture, pharmaceutical therapy, usual care only); and 3. the specific type of pain such as breakthrough pain [72] , cancer-induced bone pain [73] or aromatase inhibitor-associated arthralgia [74] . Evidence synthesis for non-randomised studies Firstly, we will tabulate the characteristics of each of the non-randomised studies, the outcome measures and the reported results. Where possible, studies will be grouped according to study type, type of acupuncture intervention, type of control (if applicable), type of cancer pain, and study quality.
Page 15
Concluding remarks Anticipated limitations and challenges include issues relating the quality of the available evidence as outlined above, diversity between clinical studies precluding data pooling in meta-analyses, small sample sizes limiting confidence in outcomes, and difficulties in synthesising and grading evidence from different types of clinical studies. Heterogeneity between the included studies is likely to lead to bias in the results; therefore we will exercise caution in the interpretation of the results and take a critical approach when assessing the overall evidence [94-96].
Comment 6: Evidence synthesis -how will the evidence from non-RCT studies be summarised? How can you usefully include this in a review of systematic reviews? For example, will you be looking for trends?
Response: Thank you for these questions. These issues were not adequately addressed in the original manuscript. In the revised version we have made the distinctions between the three components of the proposed study more clear. We have also added a section on comparing the evidence from the RCTs and non-controlled studies. Changes to MS: Page 12-13 Evidence synthesis for non-randomised studies Firstly, we will tabulate the characteristics of each of the non-randomised studies, the outcome measures and the reported results. Where possible, studies will be grouped according to study type, type of acupuncture intervention, type of control (if applicable), type of cancer pain, and study quality. We will compare the results of the meta-analyses of the RCTs with the reported results of nonrandomised studies when the studies are similar in terms of acupuncture type and type of cancer pain. If the results for the effects of the RCTs and non-randomised studies are consistent and show the same trend, the evidence from the non-randomised studies may provide support that an effect is likely to exist or not exist. On the other hand, if the findings from the non-randomised studies are inconsistent with the evidence from the RCTs, we should be more cautious in the interpretation of the RCT evidence.
In balancing the two bodies of evidence we will need to take a number of factors into consideration including the numbers of participants in the studies, the quality of the studies, and the clinical relevance of the interventions. In synthesising the results of the different types of clinical studies we will consider the non-randomized studies as complementary to the randomized controlled trials [44] .
Comment 7: Discussion -this section isn't really a discussion. It is more of a recap on what has already been said. Perhaps it needs the title 'Concluding remarks' instead?
Response: Thank you for the considerate suggestion. We have changed this to 'Concluding remarks' and added additional detail on issues we will need to consider and anticipated limitation of the proposed study.
Changes to MS: Page 13-15 Concluding remarks This review will build upon previous assessments of the evidence for acupuncture and related therapies in the management of cancer pain, by synthesising the results of previous systematic reviews, conducting updated meta-analyses of the outcomes of randomised controlled clinical trials, summarising evidence from non-randomised clinical studies, and synthesising evidence from multiple sources. In assessing the results of non-randomised studies a number of issues will need consideration including the sources of bias in the selection of participants, confounding effects of variability in baseline characteristics, issues relating to potential bias in participant reported outcomes, and the effects of attrition bias [76] [77] [78] [79] . In synthesising and comparing the results of non-randomised studies and RCTs we will need to pay attention to issues relating to the external validity of the interventions, whether the reported results from these clinical studies may be generalised to clinical populations, and whether the interventions reflect current clinical practice [80] [81] [82] . In cases where no RCT evidence is available for a particular intervention, type of cancer pain or outcome measure, we will need to base assessments on the available non-randomised studies while acknowledging the limitations of this level of evidence [44] . In such cases the non-randomised studies may indicate future directions for RCTs, for example the pilot study on acupuncture for cancer-induced bone pain [38] and the pragmatic pilot study on acupuncture for uncontrolled cancer pain [39] both suggest that further RCTs are warranted. Syndrome/pattern (zheng) differentiation is an essential notion in the theory of Chinese medicine that informs the selection and application of therapeutic interventions [83] . Randomized controlled trials and systematic reviews have examined the effects of syndrome differentiation in a number of disorders [84 85]. Syndromes distribution among advanced cancer patients with opioid-related constipation has been determined by a cross-sectional study [86] and treatment based on syndrome differentiation has been suggested [65] . Where possible, this review will examine effects related to the application of syndrome/pattern differentiation in the include studies and determine any implications for future clinical studies. A likely limitation with the overall quality of the evidence is inadequate methodological reporting in many articles published in Chinese. CONSORT and STRICTA have not been adopted by many Chinese language journals and information required for assessment of risk of bias may not be available in reports of RCTs [87] [88] [89] [90] . Poor quality of reporting in RCTs on acupuncture for cancer pain in Chinese journals makes it difficult to assess the validity of the results [91] . These issues will be considered when conducting sensitivity analyses based on methodological quality and when interpreting results [92] .
The proposed review has several strengths. The umbrella review component will not only provide an overview of the field but will also identify issues relating to meta-analysis in a condition as diverse as cancer pain and highlight considerations that will need to be taken into account in the systematic review component. A strength of the systematic review component is the inclusion of multiple Chinese and English language databases and grey literature which should ensure a comprehensive search of the literature. A further strength is any meta-analyses will be informed by rigorous methodology as detailed in the Cochrane Handbook for Systematic Reviews of Interventions [93] . The addition of the component on non-randomised studies will strengthen the overall project by providing an extended coverage of the clinical literature which may provide supporting evidence to complement the RCT literature and fill any clinically-relevant gaps. Anticipated limitations and challenges include issues relating the quality of the available evidence as outlined above, diversity between clinical studies precluding data pooling in meta-analyses, small sample sizes limiting confidence in outcomes, and difficulties in synthesising and grading evidence from different types of clinical studies. Heterogeneity between the included studies is likely to lead to bias in the results; therefore we will exercise caution in the interpretation of the results and take a critical approach when assessing the overall evidence [94] [95] [96] . Despite of these anticipated limitations, evaluating the effectiveness of acupuncture for cancer pain is of great importance for clinical practice given the challenges of pain alleviation in patient care [1] [2] [3] . We will consider the issues relating to the scope and overlap of systematic reviews included in the umbrella review [97] , whether their conclusions are affected by the results of the updated metaanalysis, and whether the results reported by the non-randomised studies are consistent or inconsistent with the results of the meta-analyses. By identifying the strengths, weaknesses and any gaps in the available clinical evidence with regard to particular types of acupuncture interventions or particular outcomes that have been assessed in clinical studies, the results of this review can inform future clinical research. Furthermore, by conducting a comprehensive evaluation of multiple types of studies we anticipate identifying promising acupuncture interventions for specific clinical applications in the management of cancer pain.
Reviewer 3: Su Min
Comment: Authors wanted to make a meta-analysis of the effectiveness of acupuncture for cancer pain. For the purposes, they included almost all articles about the acupuncture for cancer, including English or Chinese articles, and RCT or non-RCT articles. However, with these criteria, many biases will be found in this meta-analysis, and the conclusion will be affected by these biases. And for many Chinese articles, the quality of the original article is poor because many Chinese articles don't report the methods of randomization, blinding and so on. The authors should clarify how to solve the problems.
Response: Thank you for these comments. In the original version we did not provide sufficient detail on these aspects. The scope of the proposed study is intentionally broad since we aim to provide an overview of the current state of the evidence to inform both clinical practice and the development of future clinical trials. For each of the three components of the study we will assess the quality of individual studies according to corresponding tools of assessment (AMSTAR, Risk of Bias, and Newcastle-Ottawa Scale). In the revised manuscript we have added the anticipated limitations of the review including the issue of study quality and we will use sub-group and sensitivity analyses to investigate issues relating to the types of acupuncture, types of cancer pain and the quality of the clinical trials.
